Investing Profile

Shahzad Malik

InvestorVC

General Partner at Advent Life Sciences

Your Intro Paths to Shahzad Malik

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Shahzad is a member of

Mckinsey & Company Network

309 CONNECTIONS

University of Oxford Network

267 CONNECTIONS

University of Cambridge Network

258 CONNECTIONS

NHS Network

11 CONNECTIONS

Find Shahzad Malik on

Current Investing Position

Investment Range

$25K - $5.0M

Sweet Spot

$1M

Investments On Record

Shahzad Malik is on these Sector & Stage Rankings

Shahzad Malik's Investments On Record (9)

Company	StageDateRound Size	Total Raised
Relief Cardiovascular	Series AJan 2025$12M	$12M
Co-investors: Maria Berkman (Broadview Ventures)
Moximed	Series DAug 2024$61M Series CAug 2022$40M Series CMar 2017$50M	$200M
Co-investors: Josh Makower (New Enterprise Associates (NEA)), Matthew McAviney (New Enterprise Associates (NEA)), Tiffany Le (New Enterprise Associates (NEA))
MiroBio	Series BJun 2022$97M Series AOct 2019$33M	$130M
Co-investors: Deborah Harland (SR One)
Wondr Medical	SeedJun 2022$15M	$15M
Proximie	Series CJun 2022$80M	$130M
Co-investors: Tim Draper (Draper Associates), Jon Lim (F-Prime Capital Partners), Noor Sweid (SparkLabs Global Ventures), Ryan Drant (Questa Capital), Ambar Bhattacharyya (Maverick Ventures Israel), Curtis Chambers
Iterum Therapeutics	Series BMay 2017$65M	$110M
Co-investors: Brent Ahrens (Canaan Partners), James Healy (Sofinnova Investments), Patrick Heron (Frazier Healthcare Partners), Mark Chin (Jmi Equity), Tracy Saxton (Dolby Family Ventures)
Acutus Medical	Series CMar 2016$75M Series ASep 2011$5M	$210M
Co-investors: Drew Oetting (8VC), Noah Lewis (GE Ventures)
Versartis	Series DOct 2013$20M Series CJul 2013$12M Series CJan 2013$25M Series BFeb 2011$21M	$130M
Co-investors: Mike Dybbs (Samsara BioCapital)